Pages that link to "Q34563439"
Jump to navigation
Jump to search
The following pages link to Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo (Q34563439):
Displaying 50 items.
- Resveratrol in prostate diseases - a short review (Q24601444) (← links)
- Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms (Q24648759) (← links)
- Resveratrol: a review of preclinical studies for human cancer prevention (Q24675163) (← links)
- Chemoprevention of Breast Cancer by Dietary Polyphenols (Q26773449) (← links)
- Pigment epithelium-derived factor: clinical significance in estrogen-dependent tissues and its potential in cancer therapy (Q26777495) (← links)
- Phytochemicals as Innovative Therapeutic Tools against Cancer Stem Cells (Q26799995) (← links)
- An Organ System Approach to Explore the Antioxidative, Anti-Inflammatory, and Cytoprotective Actions of Resveratrol (Q26800907) (← links)
- Broad targeting of angiogenesis for cancer prevention and therapy (Q27002903) (← links)
- Resveratrol treatment delays growth plate fusion and improves bone growth in female rabbits (Q27311638) (← links)
- Phytoestrogens and breast cancer prevention: possible mechanisms of action (Q28276620) (← links)
- Transient transfection of a wild-type p53 gene triggers resveratrol-induced apoptosis in cancer cells (Q28485155) (← links)
- Resveratrol-Induced Vascular Progenitor Differentiation towards Endothelial Lineage via MiR-21/Akt/β-Catenin Is Protective in Vessel Graft Models (Q28910228) (← links)
- Therapeutic potential of resveratrol: the in vivo evidence (Q29547413) (← links)
- Targeting neuropilin-1 to inhibit VEGF signaling in cancer: Comparison of therapeutic approaches (Q33267903) (← links)
- Differences in the tumor microenvironment between African-American and European-American breast cancer patients (Q33410258) (← links)
- Determination of Flavonoids and Resveratrol in Wine by Turbulent-Flow Chromatography-LC-MS (Q33442922) (← links)
- Resveratrol and cancer: focus on in vivo evidence (Q33578943) (← links)
- Resveratrol regulates pathologic angiogenesis by a eukaryotic elongation factor-2 kinase-regulated pathway (Q33578980) (← links)
- Inhibition of mammary tumor growth and metastases to bone and liver by dietary grape polyphenols (Q33967930) (← links)
- Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways (Q34010001) (← links)
- Resveratrol, a natural antioxidant, has a protective effect on liver injury induced by inorganic arsenic exposure (Q34043077) (← links)
- Anti-angiogenic effects of resveratrol mediated by decreased VEGF and increased TSP1 expression in melanoma-endothelial cell co-culture (Q34306523) (← links)
- Differential regulation of estrogen receptors α and β by 4-(E)-{(4-hydroxyphenylimino)-methylbenzene,1,2-diol}, a novel resveratrol analog. (Q34332592) (← links)
- Dietary grape polyphenol resveratrol increases mammary tumor growth and metastasis in immunocompromised mice (Q34539310) (← links)
- Resveratrol increases vascular oxidative stress resistance (Q34573984) (← links)
- Resveratrol induces long-lasting IL-8 expression and peculiar EGFR activation/distribution in human keratinocytes: mechanisms and implications for skin administration (Q34635356) (← links)
- Natural antioxidants exhibit chemopreventive characteristics through the regulation of CNC b-Zip transcription factors in estrogen-induced breast carcinogenesis (Q34641803) (← links)
- Resveratrol: challenges in translation to the clinic--a critical discussion (Q34673721) (← links)
- The anti-tumor effect of resveratrol alone or in combination with immunotherapy in a neuroblastoma model. (Q34982031) (← links)
- The sustained delivery of resveratrol or a defined grape powder inhibits new blood vessel formation in a mouse model of choroidal neovascularization. (Q35036502) (← links)
- Identification and validation of Notch pathway activating compounds through a novel high-throughput screening method. (Q35050983) (← links)
- Resveratrol attenuates diabetic nephropathy via modulating angiogenesis (Q35061522) (← links)
- Subchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activity (Q35570811) (← links)
- Diverse animal models to examine potential role(s) and mechanism of endocrine disrupting chemicals on the tumor progression and prevention: Do they have tumorigenic or anti-tumorigenic property? (Q35653376) (← links)
- Epigenetic Regulation of miRNAs and Breast Cancer Stem Cells (Q35673753) (← links)
- Oncogenicity evaluation of resveratrol in p53( /-) (p53 knockout) mice (Q35758133) (← links)
- High-throughput genotoxicity assay identifies antioxidants as inducers of DNA damage response and cell death. (Q35887278) (← links)
- 4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol}, 1 a novel resveratrol analog, differentially regulates estrogen receptors α and β in breast cancer cells (Q35955076) (← links)
- Ginsenoside Rb1 inhibits tube-like structure formation of endothelial cells by regulating pigment epithelium-derived factor through the oestrogen beta receptor (Q35995196) (← links)
- Complementary and alternative medicines in prostate cancer: from bench to bedside? (Q36051522) (← links)
- Sensitization of TRAIL-resistant LNCaP cells by resveratrol (3, 4', 5 tri-hydroxystilbene): molecular mechanisms and therapeutic potential (Q36059686) (← links)
- Resveratrol: French paradox revisited (Q36099455) (← links)
- Potential anticancer properties of grape antioxidants (Q36167337) (← links)
- Resveratrol protects against arsenic trioxide-induced cardiotoxicity in vitro and in vivo (Q36735847) (← links)
- Combined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model (Q36831357) (← links)
- Resveratrol in prevention and treatment of common clinical conditions of aging (Q36897454) (← links)
- Antiangiogenic activity and pharmacogenomics of medicinal plants from traditional korean medicine. (Q37077910) (← links)
- Chemopreventive potential of natural compounds in head and neck cancer (Q37097045) (← links)
- Resveratrol sensitizes tamoxifen in antiestrogen-resistant breast cancer cells with epithelial-mesenchymal transition features (Q37139076) (← links)
- LYR71, a derivative of trimeric resveratrol, inhibits tumorigenesis by blocking STAT3-mediated matrix metalloproteinase 9 expression (Q37185068) (← links)